HCA Healthcare (HCA) EBITDA (2010 - 2026)

HCA Healthcare (HCA) has 17 years of EBITDA data on file, last reported at -$566.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$566.0 million, up 62.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.6 billion (down 18.79% YoY), and the FY2025 annual result was $5.6 billion, up 9.62% from the prior year.
• EBITDA advanced to -$566.0 million in Q1 2026 per HCA's latest filing, from -$4.8 billion in the prior quarter.
• Over five years, EBITDA peaked at $2.7 billion in Q4 2022 and troughed at -$4.8 billion in Q4 2025.
• A 5-year average of $45.3 million and a median of $1.3 billion in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2024 and 2026: EBITDA tumbled 345.15% in 2024, then jumped 62.71% in 2026.
• A 5-year view of EBITDA shows it stood at $2.7 billion in 2022, then fell by 29.88% to $1.9 billion in 2023, then plunged by 345.15% to -$4.7 billion in 2024, then declined by 2.12% to -$4.8 billion in 2025, then jumped by 88.27% to -$566.0 million in 2026.
• Business Quant data shows HCA's EBITDA at -$566.0 million in Q1 2026, -$4.8 billion in Q4 2025, and -$1.7 billion in Q3 2025.